Clinical Trial

A Study of AL8326 in Non-Small Cell Lung Cancer

Name: A Study of AL8326 in Non-Small Cell Lung Cancer — clinical trial record (NCT06794957)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This trial is a multicenter, single arm, open, phase IB clinical trial, designed to evaluate the preliminary efficacy and safety of AL8326 in patients with non-small cell lung cancer (NSCLC) who relapsed or progressed after multi line treatment and failed standard treatment.

Trial Details

NCT Number	NCT06794957
Lead Sponsor	Advenchen Laboratories, LLC
Conditions	Non-small Cell Lung Cancer
Enrollment	158 participants
Start Date	2022-05-19
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-01-27